Funding for this research was provided by:
Medizinische Universität Wien
Text and Data Mining valid from 2019-02-13
First Online: 13 February 2019
Compliance with Ethical Standards
: Lukas W. Unger declares no potential conflict of interest. Mattias Mandorfer served as a speaker and/or consultant and/or advisory board member for AbbVie, Bristol-Myers Squibb, Gilead, Janssen, and W. L. Gore & Associates. Thomas Reiberger received payments for lectures from Roche, MSD, Boehringer-Ingelheim, and W. L. Gore & Associates; received travel support from Gilead, MSD, and Roche; received advisory board fees from Abbvie, Bayer, Boehringer-Ingelheim, MSD, and Gilead; and received grant support from Abbvie, Boehringer-Ingelheim, Gilead, W. L. Gore & Associates, Philips, and MSD.
: This article does not contain any studies with human or animal subjects performed by any of the authors.